We would like to thank Dr. David Engelke for his guidance and helpful comments on this manuscript. PJS - Ball State University laboratory startup funds; DAB - grant 1R15AI130950-01.

NOTE: The protocol was adapted from Ref. 24.
1. Obtain RNA and Enzyme of Interest
<ol>
	<li>Use in vitro transcribed RNAs internally labeled with 32P, and recombinant His6-Mod5 expressed in and purified from E. coli, as previously described24.
	<ol>
		<li>Introduce in vitro transcribed RNAs (section 3) using T7 RNA polymerase in the presence of unlabeled ATP, UTP, CTP, GTP and 10 &#181;Ci of gel-purified, ethanol-precipitated &#945;-ATP, resuspended in 1x TE (10 mM Tris-HCl pH 7.5, 0.1 mM EDTA), and stored at -80 &#176;C24.</li>
	</ol>
	</li>
	<li>Alternatively, obtain commercially available fluorescently labeled RNAs of interest. Produce the enzyme(s) of interest in any preferred expression system. 
	Caution: Internal fluorescent tags in the RNA can alter RNA structure and recognition by enzymes.</li>
</ol>
2. Prepare a 20% Polyacrylamide Denaturing Gel
Note: In order to obtain sufficient resolution of RNA fragments, a 40 cm length vertical slab gel is recommended. The width of the gel used is determined by the number of samples to be analyzed.
<ol>
	<li>Thoroughly clean glass plates. First, wash with soap and water, rinse well with deionized water, and finally clean with isopropanol and lint-free wipes.</li>
	<li>Assemble the plates and spacers.</li>
	<li>Mix the following reagents to make 100 mL of 20% acrylamide, 7.5 M urea, 1x TBE gel: 80 mL of urea gel concentrate (237.5 g/L of acrylamide, 12.5 g/L of methylene bisacrylamide, 7.5 M urea in deionized water), 10 mL of urea gel diluent (7.5M urea in deionized water), and 10 mL of urea gel buffer (0.89 M Tris-Borate-20 mM EDTA buffer pH 8.3 and 7.5 M urea). 
	NOTE: The volume of gel solution must be adjusted according to the dimensions of gel.</li>
	<li>Add 40 &#181;L of N,N,N&#8242;,N&#8242;-Tetramethylethylenediamine (TEMED) and 800 &#181;L of freshly prepared 10% ammonium persulfate (APS).</li>
	<li>Draw gel solution up into a large syringe and dispense between glass plates. Tap on glass with fingers while pouring to prevent bubble formation.</li>
	<li>Allow gel to solidify for 30 min.</li>
	<li>Clamp solidified gel onto vertical gel apparatus using binder clips.</li>
	<li>Fill upper and lower buffer chambers with 1x TBE.</li>
	<li>Two hours prior to loading the gel, pre-run the gel at 20 mA, for 2 h to allow the buffer boundary to outrun the smallest oligonucleotides - otherwise the smallest nucleotides and oligonucleotides tend to collapse at the buffer front.</li>
</ol>
3. RNA Isopentenylation Assay
<ol>
	<li>Prepare reactions in a final volume of 17 &#181;L, containing 58 mM Tris-HCl (pH 7.2), 1.2 mM ATP, 5.8 mM MgCl2, 0.2 mM DMAPP, 10 U of RNase inhibitor (e.g., SuperRNaseIn), 40,000 CPM of internally 32P-labeled RNA, 5.3 &#181;M Mod5, and 1.2 mM 2-mercaptoethanol.</li>
	<li>Incubate reactions at 37 &#176;C for 1 h.</li>
	<li>Ethanol-precipitate RNAs using 2.5 volumes (42.5 &#181;L) of 100% ethanol and 1/10 volumes (1.7 &#181;L) of 3.5 M sodium acetate pH 5.5, and place at -20 &#176;C for 1 h or overnight.</li>
	<li>Centrifuge RNA samples for 20 min at 15,400 x g and 4 &#176;C.</li>
	<li>Carefully remove the supernatant and wash the RNA pellet with 500 &#181;L of 70% ethanol.</li>
	<li>Centrifuge samples at for 5 min 15,400 x g and 4&#176;C.</li>
	<li>Carefully remove the supernatant and air-dry RNA pellets for 15 min, or until all ethanol has evaporated.</li>
	<li>Resuspend RNA pellets in 10 &#181;L of 8 M urea.</li>
	<li>Add 150 U of RNase T1 and incubate at 37 &#176;C overnight.</li>
	<li>Add 2 &#181;L of 6x loading buffer (60% glycerol, 0.1% xylene cyanol).</li>
	<li>Load 10 &#181;L of each RNA sample on a pre-run, 20% polyacrylamide, 7.5 M urea gel (see section 2 of Protocol). 
	NOTE: Radiolabeled RNA size ladders may be included as an additional mobility marker.</li>
	<li>Run gel for 2 h at 25 mA.</li>
	<li>Stop gel and remove from apparatus.</li>
	<li>Break seal between the two glass plates and remove one of the glass plates, with the gel remaining on the &#34;bottom&#34; plate. 
	NOTE: Take care not to tear the gel during this step.</li>
	<li>Place a layer of plastic wrap over the gel and expose on a phosphor screen for 3 h. Alternatively, place gel on chromatography paper and dry with a gel dryer prior to phosphor screen exposure.</li>
	<li>Image phosphor screen on a phosphor imager.</li>
</ol>

<ol><li>Boccaletto, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((MODOMICS%3A+a+database+of+RNA+modification+pathways.+2017+update%5BTitle%5D)+AND+%22Nucleic+Acids+Research%22%5BJournal%5D)">MODOMICS: a database of RNA modification pathways. 2017 update.</a> Nucleic Acids Research. 46 (D1), 303-307 (2018).</li>
<li>Lewis, C. J., Pan, T., Kalsotra, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((RNA+modifications+and+structures+cooperate+to+guide+RNA-protein+interactions%5BTitle%5D)+AND+%22Nature+Reviews%3A+Molecular+and+Cellular+Biology%22%5BJournal%5D)">RNA modifications and structures cooperate to guide RNA-protein interactions.</a> Nature Reviews: Molecular and Cellular Biology. 18 (3), 202-210 (2017).</li>
<li>Soll, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Enzymatic+modification+of+transfer+RNA%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Enzymatic modification of transfer RNA.</a> Science. 173 (3994), 293-299 (1971).</li>
<li>Schweizer, U., Bohleber, S., Fradejas-Villar, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+modified+base+isopentenyladenosine+and+its+derivatives+in+tRNA%5BTitle%5D)+AND+%22RNA+Biology%22%5BJournal%5D)">The modified base isopentenyladenosine and its derivatives in tRNA.</a> RNA Biology. 14 (9), 1197-1208 (2017).</li>
<li>Persson, B. C., Esberg, B., Olafsson, O., Bjork, G. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Synthesis+and+function+of+isopentenyl+adenosine+derivatives+in+tRNA%5BTitle%5D)+AND+%22Biochimie%22%5BJournal%5D)">Synthesis and function of isopentenyl adenosine derivatives in tRNA.</a> Biochimie. 76 (12), 1152-1160 (1994).</li>
<li>Urbonavicius, J., Qian, Q., Durand, J. M., Hagervall, T. G., Bjork, G. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improvement+of+reading+frame+maintenance+is+a+common+function+for+several+tRNA+modifications%5BTitle%5D)+AND+%22EMBO+Journal%22%5BJournal%5D)">Improvement of reading frame maintenance is a common function for several tRNA modifications.</a> EMBO Journal. 20 (17), 4863-4873 (2001).</li>
<li>Aubee, J. I., Olu, M., Thompson, K. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+i6A37+tRNA+modification+is+essential+for+proper+decoding+of+UUX-Leucine+codons+during+rpoS+and+iraP+translation%5BTitle%5D)+AND+%22RNA%22%5BJournal%5D)">The i6A37 tRNA modification is essential for proper decoding of UUX-Leucine codons during rpoS and iraP translation.</a> RNA. 22 (5), 729-742 (2016).</li>
<li>Caillet, J., Droogmans, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+cloning+of+the+Escherichia+coli+miaA+gene+involved+in+the+formation+of+delta+2-isopentenyl+adenosine+in+tRNA%5BTitle%5D)+AND+%22Journal+of+Bacteriology%22%5BJournal%5D)">Molecular cloning of the Escherichia coli miaA gene involved in the formation of delta 2-isopentenyl adenosine in tRNA.</a> Journal of Bacteriology. 170 (9), 4147-4152 (1988).</li>
<li>Soderberg, T., Poulter, C. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Escherichia+coli+dimethylallyl+diphosphate%3AtRNA+dimethylallyltransferase%3A+essential+elements+for+recognition+of+tRNA+substrates+within+the+anticodon+stem-loop%5BTitle%5D)+AND+%22Biochemistry%22%5BJournal%5D)">Escherichia coli dimethylallyl diphosphate:tRNA dimethylallyltransferase: essential elements for recognition of tRNA substrates within the anticodon stem-loop.</a> Biochemistry. 39 (21), 6546-6553 (2000).</li>
<li>Dihanich, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+and+characterization+of+MOD5%2C+a+gene+required+for+isopentenylation+of+cytoplasmic+and+mitochondrial+tRNAs+of+Saccharomyces+cerevisiae%5BTitle%5D)+AND+%22Molecular+and+Cellular+Biology%22%5BJournal%5D)">Isolation and characterization of MOD5, a gene required for isopentenylation of cytoplasmic and mitochondrial tRNAs of Saccharomyces cerevisiae.</a> Molecular and Cellular Biology. 7 (1), 177-184 (1987).</li>
<li>Lemieux, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulation+of+physiological+rates+in+Caenorhabditis+elegans+by+a+tRNA-modifying+enzyme+in+the+mitochondria%5BTitle%5D)+AND+%22Genetics%22%5BJournal%5D)">Regulation of physiological rates in Caenorhabditis elegans by a tRNA-modifying enzyme in the mitochondria.</a> Genetics. 159 (1), 147-157 (2001).</li>
<li>Golovko, A., Sitbon, F., Tillberg, E., Nicander, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Identification+of+a+tRNA+isopentenyltransferase+gene+from+Arabidopsis+thaliana%5BTitle%5D)+AND+%22Plant+Molecular+Biology%22%5BJournal%5D)">Identification of a tRNA isopentenyltransferase gene from Arabidopsis thaliana.</a> Plant Molecular Biology. 49 (2), 161-169 (2002).</li>
<li>Warner, G. J., Rusconi, C. P., White, I. E., Faust, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Identification+and+sequencing+of+two+isopentenyladenosine-modified+transfer+RNAs+from+Chinese+hamster+ovary+cells%5BTitle%5D)+AND+%22Nucleic+Acids+Research%22%5BJournal%5D)">Identification and sequencing of two isopentenyladenosine-modified transfer RNAs from Chinese hamster ovary cells.</a> Nucleic Acids Research. 26 (23), 5533-5535 (1998).</li>
<li>Golovko, A., Hjalm, G., Sitbon, F., Nicander, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cloning+of+a+human+tRNA+isopentenyl+transferase%5BTitle%5D)+AND+%22Gene%22%5BJournal%5D)">Cloning of a human tRNA isopentenyl transferase.</a> Gene. 258 (1-2), 85-93 (2000).</li>
<li>Kernohan, K. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Matchmaking+facilitates+the+diagnosis+of+an+autosomal-recessive+mitochondrial+disease+caused+by+biallelic+mutation+of+the+tRNA+isopentenyltransferase+%28TRIT1%29+gene%5BTitle%5D)+AND+%22Human+Mutations%22%5BJournal%5D)">Matchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene.</a> Human Mutations. 38 (5), 511-516 (2017).</li>
<li>Yarham, J. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Defective+i6A37+modification+of+mitochondrial+and+cytosolic+tRNAs+results+from+pathogenic+mutations+in+TRIT1+and+its+substrate+tRNA%5BTitle%5D)+AND+%22PLoS+Genetics%22%5BJournal%5D)">Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA.</a> PLoS Genetics. 10 (6), 1004424(2014).</li>
<li>Smaldino, P. J., Read, D. F., Pratt-Hyatt, M., Hopper, A. K., Engelke, D. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+cytoplasmic+and+nuclear+populations+of+the+eukaryote+tRNA-isopentenyl+transferase+have+distinct+functions+with+implications+in+human+cancer%5BTitle%5D)+AND+%22Gene%22%5BJournal%5D)">The cytoplasmic and nuclear populations of the eukaryote tRNA-isopentenyl transferase have distinct functions with implications in human cancer.</a> Gene. 556 (1), 13-18 (2015).</li>
<li>Lamichhane, T. N., Mattijssen, S., Maraia, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+cells+have+a+limited+set+of+tRNA+anticodon+loop+substrates+of+the+tRNA+isopentenyltransferase+TRIT1+tumor+suppressor%5BTitle%5D)+AND+%22Molecular+and+Cellular+Biology%22%5BJournal%5D)">Human cells have a limited set of tRNA anticodon loop substrates of the tRNA isopentenyltransferase TRIT1 tumor suppressor.</a> Molecular and Cellular Biology. 33 (24), 4900-4908 (2013).</li>
<li>Swoboda, R. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Antimelanoma+CTL+recognizes+peptides+derived+from+an+ORF+transcribed+from+the+antisense+strand+of+the+3%27+untranslated+region+of+TRIT1%5BTitle%5D)+AND+%22Molecular+Therapy+Oncolytics%22%5BJournal%5D)">Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.</a> Molecular Therapy Oncolytics. 1, 14009(2015).</li>
<li>Yue, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Identification+of+breast+cancer+candidate+genes+using+gene+co-expression+and+protein-protein+interaction+information%5BTitle%5D)+AND+%22Oncotarget%22%5BJournal%5D)">Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information.</a> Oncotarget. 7 (24), 36092-36100 (2016).</li>
<li>Chen, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Association+of+polymorphisms+and+haplotype+in+the+region+of+TRIT1%2C+MYCL1+and+MFSD2A+with+the+risk+and+clinicopathological+features+of+gastric+cancer+in+a+southeast+Chinese+population%5BTitle%5D)+AND+%22Carcinogenesis%22%5BJournal%5D)">Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.</a> Carcinogenesis. 34 (5), 1018-1024 (2013).</li>
<li>Spinola, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Identification+and+functional+characterization+of+the+candidate+tumor+suppressor+gene+TRIT1+in+human+lung+cancer%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Identification and functional characterization of the candidate tumor suppressor gene TRIT1 in human lung cancer.</a> Oncogene. 24 (35), 5502-5509 (2005).</li>
<li>Spinola, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ethnic+differences+in+frequencies+of+gene+polymorphisms+in+the+MYCL1+region+and+modulation+of+lung+cancer+patients%27+survival%5BTitle%5D)+AND+%22Lung+Cancer%22%5BJournal%5D)">Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.</a> Lung Cancer. 55 (3), 271-277 (2007).</li>
<li>Read, D. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Aggregation+of+Mod5+is+affected+by+tRNA+binding+with+implications+for+tRNA+gene-mediated+silencing%5BTitle%5D)+AND+%22FEBS+Letters%22%5BJournal%5D)">Aggregation of Mod5 is affected by tRNA binding with implications for tRNA gene-mediated silencing.</a> FEBS Letters. 591 (11), 1601-1610 (2017).</li>
<li>Waller, T. J., Read, D. F., Engelke, D. R., Smaldino, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+human+tRNA-modifying+protein%2C+TRIT1%2C+forms+amyloid+fibers+in+vitro%5BTitle%5D)+AND+%22Gene%22%5BJournal%5D)">The human tRNA-modifying protein, TRIT1, forms amyloid fibers in vitro.</a> Gene. 612, 19-24 (2017).</li>
<li>Suzuki, G., Shimazu, N., Tanaka, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+yeast+prion%2C+Mod5%2C+promotes+acquired+drug+resistance+and+cell+survival+under+environmental+stress%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress.</a> Science. 336 (6079), 355-359 (2012).</li>
<li>Soderberg, T., Poulter, C. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Escherichia+coli+dimethylallyl+diphosphate%3AtRNA+dimethylallyltransferase%3A+site-directed+mutagenesis+of+highly+conserved+residues%5BTitle%5D)+AND+%22Biochemistry%22%5BJournal%5D)">Escherichia coli dimethylallyl diphosphate:tRNA dimethylallyltransferase: site-directed mutagenesis of highly conserved residues.</a> Biochemistry. 40 (6), 1734-1740 (2001).</li>
<li>Lamichhane, T. N., Blewett, N. H., Maraia, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plasticity+and+diversity+of+tRNA+anticodon+determinants+of+substrate+recognition+by+eukaryotic+A37+isopentenyltransferases%5BTitle%5D)+AND+%22Rna%22%5BJournal%5D)">Plasticity and diversity of tRNA anticodon determinants of substrate recognition by eukaryotic A37 isopentenyltransferases.</a> Rna. 17 (10), 1846-1857 (2011).</li>
<li>Lamichhane, T. N., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/23716598">Lack of tRNA modification isopentenyl-A37 alters mRNA decoding and causes metabolic deficiencies in fission yeast.</a> Molecular and Cellular Biology. 33 (15), 2918-2929 (2013).</li>
<li>Laten, H., Gorman, J., Bock, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isopentenyladenosine+deficient+tRNA+from+an+antisuppressor+mutant+of+Saccharomyces+cerevisiae%5BTitle%5D)+AND+%22Nucleic+Acids+Research%22%5BJournal%5D)">Isopentenyladenosine deficient tRNA from an antisuppressor mutant of Saccharomyces cerevisiae.</a> Nucleic Acids Research. 5 (11), 4329-4342 (1978).</li>
<li>Etcheverry, T., Colby, D., Guthrie, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+precursor+to+a+minor+species+of+yeast+tRNASer+contains+an+intervening+sequence%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">A precursor to a minor species of yeast tRNASer contains an intervening sequence.</a> Cell. 18 (1), 11-26 (1979).</li>
<li>Yan, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+high-throughput+quantitative+approach+reveals+more+small+RNA+modifications+in+mouse+liver+and+their+correlation+with+diabetes%5BTitle%5D)+AND+%22Analytical+Chemistry%22%5BJournal%5D)">A high-throughput quantitative approach reveals more small RNA modifications in mouse liver and their correlation with diabetes.</a> Analytical Chemistry. 85 (24), 12173-12181 (2013).</li>
<li>Su, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantitative+analysis+of+ribonucleoside+modifications+in+tRNA+by+HPLC-coupled+mass+spectrometry%5BTitle%5D)+AND+%22Nature+Protocols%22%5BJournal%5D)">Quantitative analysis of ribonucleoside modifications in tRNA by HPLC-coupled mass spectrometry.</a> Nature Protocols. 9 (4), 828-841 (2014).</li>
<li>Jonkhout, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+RNA+modification+landscape+in+human+disease%5BTitle%5D)+AND+%22Rna%22%5BJournal%5D)">The RNA modification landscape in human disease.</a> Rna. 23 (12), 1754-1769 (2017).</li>
<li>Dominissini, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+dynamic+N%281%29-methyladenosine+methylome+in+eukaryotic+messenger+RNA%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA.</a> Nature. 530 (7591), 441-446 (2016).</li>
<li>Meyer, K. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comprehensive+analysis+of+mRNA+methylation+reveals+enrichment+in+3%27+UTRs+and+near+stop+codons%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.</a> Cell. 149 (7), 1635-1646 (2012).</li>
<li>Squires, J. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Widespread+occurrence+of+5-methylcytosine+in+human+coding+and+non-coding+RNA%5BTitle%5D)+AND+%22Nucleic+Acids+Research%22%5BJournal%5D)">Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA.</a> Nucleic Acids Research. 40 (11), 5023-5033 (2012).</li>
<li>Schwartz, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transcriptome-wide+mapping+reveals+widespread+dynamic-regulated+pseudouridylation+of+ncRNA+and+mRNA%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.</a> Cell. 159 (1), 148-162 (2014).</li>
<li>Schwartz, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((High-resolution+mapping+reveals+a+conserved%2C+widespread%2C+dynamic+mRNA+methylation+program+in+yeast+meiosis%5BTitle%5D)+AND+%22Cell%22%5BJournal%5D)">High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis.</a> Cell. 155 (6), 1409-1421 (2013).</li>
<li>Behm-Ansmant, I., Helm, M., Motorin, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Use+of+specific+chemical+reagents+for+detection+of+modified+nucleotides+in+RNA%5BTitle%5D)+AND+%22Journal+of+Nucleic+Acids%22%5BJournal%5D)">Use of specific chemical reagents for detection of modified nucleotides in RNA.</a> Journal of Nucleic Acids. 2011, 408053(2011).</li>
<li>Novikova, I. V., Hennelly, S. P., Sanbonmatsu, K. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Tackling+structures+of+long+noncoding+RNAs%5BTitle%5D)+AND+%22International+Journal+of+Molecular+Sciences%22%5BJournal%5D)">Tackling structures of long noncoding RNAs.</a> International Journal of Molecular Sciences. 14 (12), 23672-23684 (2013).</li>
</ol>

None to disclose.

RNA modifications continue to be shown to play ever more important and diverse roles in cellular and organismal function. As such, the development of assays to interrogate RNA modifying enzymes is central to better understanding the fundamental aspects of biology. This protocol describes a high-resolution in vitro assay to characterize the tRNA modification activity of Mod5.
This protocol has the distinct advantage of providing a direct, and easily interpretable readout of isopentenyl...

At least 163 distinct posttranscriptional RNA modifications have been identified, with these modifications conferring diverse and context-dependent functions to RNAs, directly influencing RNA structure, and affecting interactions of RNA with other molecules1,2. As the appreciation for the number and variety of RNA modifications increases, it is critical to develop assays that can reliably interrogate both the RNA modifications and the enzymes that catalyze them.
One of the first RNA modifications to be identified occurs at base 37 in tRNAs, adjacent to the anti-codon on the 3&#39; side3,4. An isopentenyl group is transferred from dimethylallylpyrophosphate (DMAPP) to the N6 position of adenosine 37 (i6A37) 3,5 on a subset of both cytoplasmic and mitochondrial tRNAs. i6A37 improves translation fidelity and efficiency by increasing the tRNA&#39;s affinity for the ribosome4,6 and i6A37 is important for stress response in bacteria7. The enzymes that perform this modification are termed tRNA isopentenyl transferases and are highly conserved in bacteria8,9, fungi10, worms11, plants12, and higher eukaryotes13, including humans14.
Mutations in the human tRNA isopentenyl transferase gene, TRIT1, are associated with human disease. For example, a mutation in TRIT1 is correlated with a severe mitochondrial disease, likely caused by a defect in mitochondrial protein synthesis15,16. Furthermore, TRIT1 has been described as a tumor suppressor gene17,18 and is implicated in several types of cancers including melanoma19, breast20, gastric21, and lung cancers22,23. Finally, TRIT1 and Mod5 (Saccharomyces cerevisiae) isopentenyl transferases are aggregation-prone proteins that form prion-like amyloid fibers24,25,26. These observations potentially implicate tRNA isopentenyl transferases in neurodegenerative diseases, although direct evidence for this has not yet been shown.
Given the role that isopentenyl transferases play in translation and disease, methods that directly measure i6A isopentenyl transferase activity are important for a mechanistic understanding of these enzymes under normal and disease states. An increasing number of methods are available to detect i6A RNA modifications, including in vitro isopentenylation assays, positive hybridization in the absence of i6A (PHA6) assays, thin layer chromatography (TLC), amino acid acceptance activity assays, and mass spectrometry approaches (Reviewed in Ref. 4).
An in vitro isopentenylation assay has been described that utilizes 14C-DMAPP and unlabeled tRNAs. In this assay, radioactive carbon is transferred to RNA from 14C-DMAPP by the isopentenyl transferase. While this assay is highly sensitive, it is often difficult to determine the specific residue that is modified9,20,27. PHA6 assays rely on the bulky i6A modification interfering with hybridization of a 32P-labeled probe spanning the modified residue. As such, hybridization is greater in the absence of an i6A modification18,28,29. PHA6 assays are highly sensitive, and capable of analyzing total RNA extracted from cellular lysates. Additionally, the ability to design probes specific to the RNA of interest gives this method substantial target flexibility. However, PHA6 assays are limited to the characterization of modifications that occur on residues within the targeted region of the probe and therefore are less likely to identify novel modification sites. In addition, as absence of binding is indicative of modification, other modifications or mutations that affect RNA binding will confound data analysis.
Another approach combines benzyl DEAE cellulose (BD) cellulose chromatography with amino acid acceptance activity as a readout of i6A modifications in tRNA30. This approach directly assays the function of the i6A modification, but it is an indirect approach to detect i6A modification and lacks resolution to map modifications to a specific residue in the RNA. A TLC approach has been used to detect total tRNA i6A modifications. In this approach, internally 32P-labeled tRNAs are digested to single nucleotides and two-dimensional TLC analysis is used to identify isopentenylation. This approach is highly sensitive in detecting total i6A in a given RNA sample but upon digestion, all sequence information is lost; thus, the investigator has no way of determining which residues have been modified31.
More recently, liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods have been developed that quantitatively compare total RNA modifications between species, cell types, and experimental conditions32,33,34. A limitation of this methodology is that it is less able to determine the identity and position within the RNA from which the modified nucleoside was derived34. Furthermore, the expertise and equipment necessary to execute these experiments limit the practicality of this approach.
In addition, several next-generation sequencing technologies have been developed to map RNA modifications transcriptome-wide34. Immunoprecipitation of RNAs with antibodies specific to a particular modification (RIP-Seq) enable the investigator to identify all sequences containing a specific modification35,36. Additionally, reverse transcriptase-based approaches such as Chem-Seq and non-random mismatch sequencing rely on perturbations of the reverse transcription reaction at the modified residues37,38,39. Despite the advantage of these techniques to map RNA modifications transcriptome-wide, RIP-seq and Chem-Seq technologies are limited by the lack of reliable antibodies or reactive chemicals available for each specific modification, respectively34. Furthermore, reverse transcriptase enzymes required to perform Chem-Seq and non-random mismatch sequencing techniques can be impeded by stable RNA structures. The highly modified and structurally stable nature of tRNAs make them especially difficult to interrogate using these techniques. To date, next-generation sequencing-based technologies have not yet been utilized to map i6A modifications34.
Herein, we describe a simple and direct approach to detect i6A tRNA modifications in vitro. This method utilizes incubation of RNAs with recombinant S. cerevisiae isopentenyl transferase (Mod5), followed by RNase T1 digestion, and 1-dimensional gel electrophoresis analysis to map i6A modifications. This approach is direct and requires little specialized expertise to analyze the data. Furthermore, this method is adaptable to other RNA modifying enzymes, including enzymes that covalently change the molecular weight of RNA or an RNA&#39;s mobility through a gel.

<table><tbody><tr><td>&lt;strong&gt;Reagents&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>UreaGel Concentrate</td><td>National Diagnostics</td><td>EC-833</td><td>As part of a kit</td></tr><tr><td>UreaGel Diluent</td><td>National Diagnostics</td><td>EC-833</td><td>As part of a kit</td></tr><tr><td>UreaGel Buffer</td><td>National Diagnostics</td><td>EC-833</td><td>As part of a kit</td></tr><tr><td>10x TBE</td><td>National Diagnostics</td><td>EC-833</td><td>As part of a kit</td></tr><tr><td>Ammonium persulfate (APS)</td><td>Sigma-Aldrich</td><td>7727-54-0</td><td></td></tr><tr><td>N,N,N&amp;prime;,N&amp;prime;-Tetramethylethylenediamine (TMED)</td><td>Sigma-Aldrich</td><td>T9281</td><td></td></tr><tr><td>Tris base</td><td>Sigma-Aldrich</td><td>T1503</td><td></td></tr><tr><td>Boric acid</td><td>Sigma-Aldrich</td><td>10043-35-3</td><td></td></tr><tr><td>EDTA</td><td>Sigma-Aldrich</td><td>60-00-4</td><td></td></tr><tr><td>ATP</td><td>Sigma-Aldrich</td><td>34369-07-8</td><td></td></tr><tr><td>MgCl&lt;sub&gt;2&lt;/sub&gt;</td><td>Sigma-Aldrich</td><td>7786-30-3</td><td></td></tr><tr><td>DMAPP</td><td>Caymen Chemical</td><td>1186-30-7</td><td></td></tr><tr><td>Super RNaseIN</td><td>ThermoFisher Scientific</td><td>AM2694</td><td></td></tr><tr><td>2-mercaptoethanol</td><td>Sigma-Aldrich</td><td>60-24-2</td><td></td></tr><tr><td>Ethanol</td><td>Sigma-Aldrich</td><td>64-17-5</td><td></td></tr><tr><td>Sodiume acetate</td><td>Sigma-Aldrich</td><td>127-09-3</td><td></td></tr><tr><td>Rnase T1</td><td>ThermoFisher Scientific</td><td>EN0541</td><td></td></tr><tr><td>Glycerol</td><td>Sigma-Aldrich</td><td>56-81-5</td><td></td></tr><tr><td>Xylene cyanol</td><td>Sigma-Aldrich</td><td>2650-17-1</td><td></td></tr><tr><td>&lt;strong&gt;Equipment and Supplies&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Short glass plates (20-40 cm W x 40 cm L)</td><td>The Gel Company</td><td></td><td></td></tr><tr><td>Long glass plates (20-40 cm W x 40 cm L)</td><td>The Gel Company</td><td></td><td></td></tr><tr><td>Vertical gel apparatus</td><td>The Gel Company</td><td>S2-3040</td><td></td></tr><tr><td>50 mL disposable syringe</td><td>Fisher Scientific</td><td>03-377-26</td><td></td></tr><tr><td>Stainless steel binder clips</td><td>Idea Scientific</td><td>1066</td><td></td></tr><tr><td>Phosphoscreen</td><td>Sigma-Aldrich</td><td>28-9564-74</td><td></td></tr><tr><td>Plastic wrap</td><td>(local grocery store)</td><td></td><td></td></tr></tbody></table>

an in vitro assay to detect trna-isopentenyl transferase activity

N6-isopentenyladenosine RNA modifications are functionally diverse and highly conserved among prokaryotes and eukaryotes. One of the most highly conserved N6-isopentenyladenosine modifications occurs at the A37 position in a subset of tRNAs. This modification improves translation efficiency and fidelity by increasing the affinity of the tRNA for the ribosome. Mutation of enzymes responsible for this modification in eukaryotes are associated with several disease states, including mitochondrial dysfunction and cancer. Therefore, understanding the substrate specificity and biochemical activities of these enzymes is important for understanding of normal and pathologic eukaryotic biology. A diverse array of methods has been employed to characterize i6A modifications. Herein is described a direct approach for the detection of isopentenylation by Mod5. This method utilizes incubation of RNAs with a recombinant isopentenyl transferase, followed by RNase T1 digestion, and 1-dimensional gel electrophoresis analysis to detect i6A modifications. In addition, the potential adaptability of this protocol to characterize other RNA-modifying enzymes is discussed.

Mod5 was incubated with a tyrosine tRNA or serine tRNA in the presence or absence of DMAPP. Following the modification reaction, products were RNase T1-digested, which cleaves the 3&#39; end of all guanosines leaving a 3&#39; guanosine monophosphates (GMP)24 (Figure 1). Full digestion of the RNAs produces a predictable pattern of radiolabeled fragments (Figure 2A), which are then resolved ...

Watch this Scientific Journal Video about An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity at JoVE.com

An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity

Here, we describe a protocol for the biochemical characterization of the yeast RNA-modifying enzyme, Mod5, and discuss how this protocol could be applied to other RNA-modifying enzymes.

An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity

N6-isopentenyladenosine RNA modifications are functionally diverse and highly conserved among prokaryotes and eukaryotes. One of the most highly conserved ...

an-in-vitro-assay-to-detect-trna-isopentenyl-transferase-activity

Research

JoVE Journal

Biochemistry

6.9K Views.  Ball State University. Het algemene doel van dit protocol is om biochemisch te karakteriseren tRNA-Isopentenyl Transferase Activiteit In Vitro. Deze methode is nuttig voor de in-vitro detectie en karakterisering van tRNA-isopentenyl transferase activiteit van gezuiverde recombinante enzymen. Het belangrijkste voordeel van deze techniek is dat het een eenvoudige en directe test wordt gebruikt om een covalente RNA-modificatie te detecteren.Hoewel deze methode inzicht geeft in tRNA-isopentenyl transferase activ...

Video: An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity

In Vitro Transcription Assays and Their Application in Drug Discovery

In vitro transcription assays have been developed and widely used for many years to study the molecular mechanisms involved in transcription. This process requires multi-subunit DNA-dependent RNA polymerase (RNAP) and a series of transcription factors that act to modulate the activity of RNAP during gene expression. Sequencing gel electrophoresis of radiolabeled transcripts is used to provide detailed mechanistic information on how transcription proceeds and what parameters can affect it. In this paper we describe the protocol to study how the essential elongation factor NusA regulates transcriptional pausing, as well as a method to identify an antibacterial agent targeting transcription initiation through inhibition of RNAP holoenzyme formation. These methods can be used a as platform for the development of additional approaches to explore the mechanism of action of the transcription factors which still remain unclear, as well as new antibacterial agents targeting transcription which is an underutilized drug target in antibiotic research and development.

In Vitro Transcription Assays and Their Application in Drug Discovery

In this manuscript, we describe a protocol to functionally examine transcription and the inhibitory activity of antibacterial agents targeting bacterial transcription.

In vitro transcription assays have been developed and widely used for many years to study the molecular mechanisms involved in transcription. This process ...

Genetics

In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme

Protozoan parasites are among the most devastating infectious agents of humans responsible for a variety of diseases including amebiasis, which is one of the three most common causes of death from parasitic disease. The agent of amebiasis is the amoeba parasite Entamoeba histolytica that exists under two stages: the infective cyst found in food or water and the invasive trophozoite living in the intestine. The clinical manifestations of amebiasis range from being asymptomatic to colitis, dysentery or liver abscesses. E. histolytica is one of the rare unicellular parasite with 5-methylcytosine (5mC) in its genome. 1, 2 It contains a single DNA methyltransferase, Ehmeth, that belongs to the Dnmt2 family. 2 A role for Dnmt2 in the control of repetitive elements has been established in E. histolytica, 3 Dictyostelium discoideum 4,5 and Drosophila. 6 Our recent work has shown that Ehmeth methylates tRNAAsp, and this finding indicates that this enzyme has a dual DNA/tRNAAsp methyltransferase activity. 7 This observation is in agreement with the dual activity that has been reported for D. discoideum and D. melanogaster. 8 The functional significance of the DNA/tRNA specificity of Dnmt2 enzymes is still unknown. To address this question, a method to determine the tRNA methyltransferase activity of Dnmt2 proteins was established. In this video, we describe a straightforward approach to prepare an adequate tRNA substrate for Dnmt2 and a method to measure its tRNA methyltransferase activity.

In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 Ehmeth Enzyme

This protocol describes the preparation of a synthetic tRNA substrate for the Entamoeba histolytica DNA/tRNA methyltransferase 2 (Dnmt2) homolog Ehmeth and the measure of its methyltransferase activity. This experimental approach can be used for investigating the activity of other Dnmt2 proteins.

Protozoan parasites are among the most devastating infectious agents of humans responsible for a variety of diseases including amebiasis, which is one of ...

Immunology and Infection

Protein-tRNA Agarose Gel Retardation Assays for the Analysis of the N6-threonylcarbamoyladenosine TcdA Function

We demonstrate methods for the expression and purification of tRNA(UUU) in Escherichia coli and the analysis by gel retardation assays of the binding of tRNA(UUU) to TcdA, an N6-threonylcarbamoyladenosine (t6A) dehydratase, which cyclizes the threonylcarbamoyl side chain attached to A37 in the anticodon stem loop (ASL) of tRNAs to cyclic t6A (ct6A). Transcription of the synthetic gene encoding tRNA(UUU) is induced in E. coli with 1 mM isopropyl &#946;-D-1-thiogalactopyranoside (IPTG) and the cells containing tRNA are harvested 24 h post-induction. The RNA fraction is purified using the acid phenol extraction method. Pure tRNA is obtained by a gel filtration chromatography that efficiently separates the small-sized tRNA molecules from larger intact or fragmented nucleic acids. To analyze TcdA binding to tRNA(UUU), TcdA is mixed with tRNA(UUU) and separated on a native agarose gel at 4 &#176;C. The free tRNA(UUU) migrates faster, while the TcdA-tRNA(UUU) complexes undergo a mobility retardation that can be observed upon staining of the gel. We demonstrate that TcdA is a tRNA(UUU)-binding enzyme. This gel retardation assay can be used to study TcdA mutants and the effects of additives and other proteins on binding.

Protein-tRNA Agarose Gel Retardation Assays for the Analysis of the N6-threonylcarbamoyladenosine TcdA Function

A protocol is presented for the production of tRNA(UUU) and the analysis of tRNA(UUU) in complex with the enzyme TcdA by agarose gel retardation assays.

We demonstrate methods for the expression and purification of tRNA(UUU) in Escherichia coli and the analysis by gel retardation assays of the binding of ...

Quantification of the Abundance and Charging Levels of Transfer RNAs in Escherichia coli

Transfer RNA (tRNA) is an essential part of the translational machinery in any organism. tRNAs bind and transfer amino acids to the translating ribosome. The relative levels of different tRNAs, and the ratio of aminoacylated tRNA to total tRNA, known as the charging level, are important factors in determining the accuracy and speed of translation. Therefore, the abundance and charging levels of tRNAs are important variables to measure when studying protein synthesis, for example under various stress conditions. Here, we describe a method for harvesting tRNA and directly measuring both the relative abundance and the absolute charging level of specific tRNA species in Escherichia coli. The tRNA is harvested in such a way that the labile bond between the tRNA and its amino acid is preserved. The RNA is then subjected to gel electrophoresis and Northern blotting, which results in separation of the charged and uncharged tRNAs. The levels of specific tRNAs in different samples can be compared due to the addition of spike-in cells for normalization. Prior to RNA purification, we add 5% of E. coli cells that overproduce the rare tRNAselC to each sample. The amount of the tRNA species of interest in a sample is then normalized to the amount of tRNAselC in the same sample. Addition of spike-in cells prior to RNA purification has the advantage over addition of purified spike-in RNAs that it also accounts for any differences in cell lysis efficiency between samples.

Quantification of the Abundance and Charging Levels of Transfer RNAs in Escherichia coli

Here we present a method for directly measuring transfer RNA charging levels from purified Escherichia coli RNA as well as a way to compare relative levels of transfer RNA, or any other short RNA, across different samples based on the addition of spike-in cells expressing a reference gene.

Transfer RNA (tRNA) is an essential part of the translational machinery in any organism. tRNAs bind and transfer amino acids to the translating ribosome. ...

Antibody-Free Assay for RNA Methyltransferase Activity Analysis

There are more than 100 chemically distinct modifications of RNA, two thirds of which consist of methylations. Interest in RNA modifications, and especially methylations, has re-emerged due to the important roles played by the enzymes that write and erase them in biological processes relevant to disease and cancer. Here, a sensitive in vitro assay for accurate analysis of RNA methylation writer activity on synthetic or in vitro transcribed RNAs is provided. This assay uses a tritiated form of S-adenosyl-methionine, resulting in direct labeling of methylated RNA with tritium. The low energy of tritium radiation makes the method safe, and pre-existing methods of tritium signal amplification, make it possible to quantify and to visualize the methylated RNA without the use of antibodies, which are commonly prone to artifacts. While this method is written for RNA methylation, few tweaks make it applicable to the study of other RNA modifications that can be radioactively labeled, such as RNA acetylation with 14C acetyl coenzyme A. Overall, this assay allows to quickly assess RNA methylation conditions, inhibition with small molecule inhibitors, or the effect of RNA or enzyme mutants, and provides a powerful tool to validate and expand results obtained in cells.

Here, an antibody-free in vitro assay for direct analysis of methyltransferase activity on synthetic or in vitro transcribed RNA is described.

There are more than 100 chemically distinct modifications of RNA, two thirds of which consist of methylations. Interest in RNA modifications, and ...

An In Vitro Single-Molecule Imaging Assay for the Analysis of Cap-Dependent Translation Kinetics

Cap-dependent protein synthesis is the predominant translation pathway in eukaryotic cells. While various biochemical and genetic approaches have allowed extensive studies of cap-dependent translation and its regulation, high resolution kinetic characterization of this translation pathway is still lacking. Recently, we developed an in vitro assay to measure cap-dependent translation kinetics with single-molecule resolution. The assay is based on fluorescently labeled antibody binding to nascent epitope-tagged polypeptide. By imaging the binding and dissociation of antibodies to and from nascent peptide&#8211;ribosome&#8211;mRNA complexes, the translation progression on individual mRNAs can be tracked. Here, we present a protocol for establishing this assay, including mRNA and PEGylated slide preparations, real-time imaging of translation, and analysis of single molecule trajectories. This assay enables tracking of individual cap-dependent translation events and resolves key translation kinetics, such as initiation and elongation rates. The assay can be widely applied to distinct translation systems and should broadly benefit in vitro studies of cap-dependent translation kinetics and translational control mechanisms.

An In Vitro Single-Molecule Imaging Assay for the Analysis of Cap-Dependent Translation Kinetics

Tracking individual translation events allows for high-resolution kinetic studies of cap-dependent translation mechanisms. Here we demonstrate an in vitro single-molecule assay based on imaging interactions between fluorescently labeled antibodies and epitope-tagged nascent peptides. This method enables single-molecule characterization of initiation and peptide elongation kinetics during active in vitro cap-dependent translation.

Cap-dependent protein synthesis is the predominant translation pathway in eukaryotic cells. While various biochemical and genetic approaches have allowed ...

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Recently, structural and biochemical studies have detailed many of the molecular events that occur in the ribosome during inhibition of protein synthesis by antibiotics and during nascent polypeptide synthesis. Some of these antibiotics, and regulatory nascent polypeptides mostly in the form of peptidyl-tRNAs, inhibit either peptide bond formation or translation termination1-7. These inhibitory events can stop the movement of the ribosome, a phenomenon termed "translational arrest". Translation arrest induced by either an antibiotic or a nascent polypeptide has been shown to regulate the expression of genes involved in diverse cellular functions such as cell growth, antibiotic resistance, protein translocation and cell metabolism8-13. Knowledge of how antibiotics and regulatory nascent polypeptides alter ribosome function is essential if we are to understand the complete role of the ribosome in translation, in every organism.
Here, we describe a simple methodology that can be used to purify, exclusively, for analysis, those ribosomes translating a specific mRNA and containing a specific peptidyl-tRNA14. This procedure is based on selective isolation of translating ribosomes bound to a biotin-labeled mRNA. These translational complexes are separated from other ribosomes in the same mixture, using streptavidin paramagnetic beads (SMB) and a magnetic field (MF). Biotin-labeled mRNAs are synthesized by run-off transcription assays using as templates PCR-generated DNA fragments that contain T7 transcriptional promoters. T7 RNA polymerase incorporates biotin-16-UMP from biotin-UTP; under our conditions approximately ten biotin-16-UMP molecules are incorporated in a 600 nt mRNA with a 25% UMP content. These biotin-labeled mRNAs are then isolated, and used in in vitro translation assays performed with release factor 2 (RF2)-depleted cell-free extracts obtained from Escherichia coli strains containing wild type or mutant ribosomes. Ribosomes translating the biotin-labeled mRNA sequences are stalled at the stop codon region, due to the absence of the RF2 protein, which normally accomplishes translation termination. Stalled ribosomes containing the newly synthesized peptidyl-tRNA are isolated and removed from the translation reactions using SMB and an MF. These beads only bind biotin-containing messages.
The isolated, translational complexes, can be used to analyze the structural and functional features of wild type or mutant ribosomal components, or peptidyl-tRNA sequences, as well as determining ribosome interaction with antibiotics or other molecular factors 1,14-16. To examine the function of these isolated ribosome complexes, peptidyl-transferase assays can be performed in the presence of the antibiotic puromycin1. To study structural changes in translational complexes, well established procedures can be used, such as i) crosslinking to specific amino acids14 and/or ii) alkylation protection assays1,14,17.

A major impediment to biochemical analyses of ribosomes containing nascent peptidyl-tRNAs has been the presence of other ribosomes in the same samples, ribosomes not involved in the translation of the specific mRNA sequence being analyzed. We developed a simple methodology to purify, exclusively, the ribosomes containing the nascent peptidyl-tRNA of interest.

Recently, structural and biochemical studies have detailed many of the molecular events that occur in the ribosome during inhibition of protein synthesis ...

Biology

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

DNA nanotechnology enables programmable self-assembly of nucleic acids into user-prescribed shapes and dynamics for diverse applications. This work demonstrates that concepts from DNA nanotechnology can be used to program the enzymatic activity of the phage-derived T7 RNA polymerase (RNAP) and build scalable synthetic gene regulatory networks. First, an oligonucleotide-tethered T7 RNAP is engineered via expression of an N-terminally SNAP-tagged RNAP and subsequent chemical coupling of the SNAP-tag with a benzylguanine (BG)-modified oligonucleotide. Next, nucleic-acid strand displacement is used to program polymerase transcription on-demand. In addition, auxiliary nucleic acid assemblies can be used as &#34;artificial transcription factors&#34; to regulate the interactions between the DNA-programmed T7 RNAP with its DNA templates. This in vitro transcription regulatory mechanism can implement a variety of circuit behaviors such as digital logic, feedback, cascading, and multiplexing. The composability of this gene regulatory architecture facilitates design abstraction, standardization, and scaling. These features will enable the rapid prototyping of in vitro&#160;genetic devices for applications such as bio-sensing, disease detection, and data storage.

We describe the engineering of a novel DNA-tethered T7 RNA polymerase to regulate in vitro transcription reactions. We discuss the steps for protein synthesis and characterization, validate proof-of-concept transcriptional regulation, and discuss its applications in molecular computing, diagnostics, and molecular information processing.

DNA nanotechnology enables programmable self-assembly of nucleic acids into user-prescribed shapes and dynamics for diverse applications. This work ...

Bioengineering

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells

Every poxvirus mRNA transcribed after viral DNA replication has an evolutionarily conserved, non-templated 5&#39;-poly(A) leader in the 5&#39;-UTR. To dissect the role of 5&#39;-poly(A) leader in mRNA translation during poxvirus infection we developed an in vitro transcribed RNA-based luciferase reporter assay. This reporter assay comprises of four core steps: (1) PCR to amplify the DNA template for in vitro transcription; (2) in vitro transcription to generate mRNA using T7 RNA polymerase; (3) Transfection to introduce in vitro transcribed mRNA into cells; (4) Detection of luciferase activity as the indicator of translation. The RNA-based luciferase reporter assay described here circumvents issues of plasmid replication in poxvirus-infected cells and cryptic transcription from the plasmid. This protocol can be used to determine translation regulation by cis-elements in an mRNA including 5&#39;-UTR and 3&#39;-UTR in systems other than poxvirus-infected cells. Moreover, different modes of translation initiation like cap-dependent, cap-independent, re-initiation, and internal initiation can be investigated using this method.

We present a protocol to study mRNA translation regulation in poxvirus-infected cells using in vitro Transcribed RNA-based luciferase reporter assay. The assay can be used for studying translation regulation by cis-elements of an mRNA, including 5&#8217;-untranslated region (UTR) and 3&#8217;-UTR. Different translation initiation modes can also be examined using this method.

Every poxvirus mRNA transcribed after viral DNA replication has an evolutionarily conserved, non-templated 5&#39;-poly(A) leader in the 5&#39;-UTR. To ...

RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes

Substantial progress has been made in determining the mechanism of mitochondrial RNA editing in trypanosomes. Similarly, considerable progress has been made in identifying the components of the editosome complex that catalyze RNA editing. However, it is still not clear how those proteins work together. Chemical compounds obtained from a high-throughput screen against the editosome may block or affect one or more steps in the editing cycle. Therefore, the identification of new chemical compounds will generate valuable molecular probes for dissecting the editosome function and assembly. In previous studies, in vitro editing assays were carried out using radio-labeled RNA. These assays are time consuming, inefficient and unsuitable for high-throughput purposes. Here, a homogenous fluorescence-based &#8220;mix and measure&#8221; hammerhead ribozyme in vitro reporter assay to monitor RNA editing, is presented. Only as a consequence of RNA editing of the hammerhead ribozyme a fluorescence resonance energy transfer (FRET) oligoribonucleotide substrate undergoes cleavage. This in turn results in separation of the fluorophore from the quencher thereby producing a signal. In contrast, when the editosome function is inhibited, the fluorescence signal will be quenched. This is a highly sensitive and simple assay that should be generally applicable to monitor in vitro RNA editing or high throughput screening of chemicals that can inhibit the editosome function.

A highly sensitive ribozyme-based assay, applicable to high-throughput screening of chemicals targeting the unique process of RNA editing in trypanosomatid pathogens, is described in this paper. Inhibitors can be used as tools for hypothesis-driven analysis of the RNA editing process and ultimately as therapeutics.

Substantial progress has been made in determining the mechanism of mitochondrial RNA editing in trypanosomes. Similarly, considerable progress has been ...

An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity

Samenvatting

Meer video's verkennen